Sodium-glucose cotransporter 2 inhibitors in frail, older people with type 2 diabetes and heart failure: do we have enough evidence to confidently support the use?

Affiliations

¹ Division of Endocrinology and Metabolism and Diabetes Centre, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece.
² Second Propedeutic Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
³ Department of Endocrinology and Metabolic Diseases, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
⁴ Department of Diabetes and Endocrinology, Epsom & St Helier University Hospitals, Surrey, UK.
⁵ Unit for Metabolic Medicine, Cardiovascular Division, Faculty of Life Sciences & Medicine, King's College, London, UK.

Editorial

Theocharis Koufakis et al. Expert Rev Clin Pharmacol. 2023 Jul-Dec.

. 2023 Jul-Dec;16(9):771-774.

doi: 10.1080/17512433.2023.2247977. Epub 2023 Aug 18.

¹ Division of Endocrinology and Metabolism and Diabetes Centre, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece.
² Second Propedeutic Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
³ Department of Endocrinology and Metabolic Diseases, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
⁴ Department of Diabetes and Endocrinology, Epsom & St Helier University Hospitals, Surrey, UK.
⁵ Unit for Metabolic Medicine, Cardiovascular Division, Faculty of Life Sciences & Medicine, King's College, London, UK.

No abstract available

Keywords: SGLT2 inhibitors; elderly; frailty; heart failure; type 2 diabetes.

Comment on

SGLT2-inhibitors are effective and safe in the elderly: The SOLD study.
Lunati ME, Cimino V, Gandolfi A, Trevisan M, Montefusco L, Pastore I, Pace C, Betella N, Favacchio G, Bulgheroni M, Bucciarelli L, Massari G, Mascardi C, Girelli A, Morpurgo PS, Folli F, Luzi L, Mirani M, Pintaudi B, Bertuzzi F, Berra C, Fiorina P. Lunati ME, et al. Pharmacol Res. 2022 Sep;183:106396. doi: 10.1016/j.phrs.2022.106396. Epub 2022 Aug 12. Pharmacol Res. 2022. PMID: 35970329